The nominating institution National University of Singapore on the breakthrough:
The current pandemic is disrupting lives and rapid on-site testing is key to containing the outbreak. However, current testing requires samples to be sent to a centralized laboratory and results can take up to a few days to be made known. We developed Epidax, a patent pending portable microfluidic based PCR diagnostic system, for the rapid on-site testing of infection. This portable diagnostic system can play an important role in bringing major disease outbreaks under control.
Tags: Covid-19, Engineering, Med-Tech, Mobile Health.